Summary Restriction fragment length polymorphism (RFLP) of the L-myc gene was examined in DNAs from primary tumour tissues and peripheral blood cells (PBC) of 76 Indian patients with squamous cell carcinoma of the oral cavity, and PBC from 101 normal healthy volunteers. The patients and the normal healthy volunteers were classified into three genetic types according to the polymorphic patterns defined by the two alleles (6.6 kb, S fragment; and 10.0 kb, L fragment). DNA isolated from the PBC of each patient always exhibited the same pattern of L-myc alleles as that observed for the corresponding tumour DNA. However, a striking correlation was found between the RFLP pattern and the stage of differentiation of the tumours, as well as the size of the tumour. Thus, a preponderance of the S fragment was observed in the poor to moderately differentiated tumours and the larger (>4 cm) sized tumours. Further, analysis of L-myc RFLP with the clinical pattern of the malignancy showed no significant correlation with nodal metastasis, TNM staging or recurrence of the tumour. The relative ratios of the three genotypes (L-L, L-S, S-S) in the oral cancer patients were not significantly different from those seen in the healthy Indians, implying no predisposition to oral cancer by either allele. However, our results showed that oral cancer patients with a genotype including an S fragment are more likely to develop a poor to moderately differentiated tumour or a larger tumour than a patient without an S fragment. The L and S alleles were equally distributed in the population, with the frequency of each allele being 0.50, consistent with Hardy-Weinberg's law.
Human oral cancer is a major cause of mortality in Third World countries, comprising 40-50% of all malignancies in several parts of India and South East Asia (Pindborg, 1984; Sanghavi, 1981) . The tumour is relatively uncommon in the Western society, constituting 2-5% of all malignancies (Field & Spandidos, 1987) . On the Indian scene, epidemiological and experimental evidence has indicated a causal relationship between chewing tobacco and oral cancer, tobacco being the 'sine qua non' of oral cancer (Gupta et al., 1988; Jussawalla & Deshpande, 1971) . However, there is a paucity of information on the molecular basis of cancer of the oral cavity and the involvement of oncogenes, which have been implicated in several human tumours, in oral cancers.
Recent studies from our laboratory have demonstrated the involvement of oncogenes in squamous cell carcinoma of the oral cavity, via amplification of myc and ras family genes (Saranath et al., 1989) . A 5-10-fold amplification of Ki-ras was reported in 17% and 30%, respectively, of the oral cancer samples investigated. Of the three well defined myc family oncogenes, we observed c-myc and N-myc amplified in 20-40% of the primary tumour tissues examined, whereas L-myc was not amplified in any of the samples.
RFLP studies of the L-myc gene have demonstrated a close association of the S (6.6 kb) fragment with metastatic potential in lung cancer (Kawashima et al., 1988) , colon and stomach cancers (Kawashima et al., 1987) , and renal cell carcinomas (Kakehi & Yoshida, 1989) . These studies indicated that the L (10.0kb) fragment was an indicator of better prognosis in the cancers. Further, Kawashima et al. (1987) observed an increased frequency of the L fragment in normal somatic cells of colon tumour patients as compared to normal individuals, thus implying the presence of the L allele as an indicator of genetic predisposition to colon tumours. In this study, we have investigated the prognostic utility of L-myc polymorphic fragments in oral cancers, and the correlation between L-myc RFLPs and the clinical pattern of squamous cell carcinoma of the oral cavity, in the Indian population.
Material and methods

Subjects
Seventy-six untreated patients (57 males, 19 females, aged 20-70 years), diagnosed as having squamous cell carcinoma of the oral cavity, were studied for L-myc RFLP. The diagnosis was based on clinical examination and histological features of the biopsy material. The various sites included: buccal mucosa, 34 patients; tongue, 19 patients; lower alveolus, 21 patients; and floor of the mouth, two patients. The tumour tissues were resected near the advancing edge of the tumour, avoiding the more necrotic central region. Peripheral blood cells (PBC) were collected from the oral cancer patients on admission to the surgical ward of Tata Memorial Hospital. PBC were also obtained from 101 normal healthy volunteers, and used as controls to determine frequency of the L-myc alleles in the normal population. More than 80% of the patients as well as the normals belonged to the Hindu community. Samples were frozen in liquid nitrogen until isolation of DNA. For the analysis, samples were serially coded irrespective of the clinicopathological status of the patient.
DNA extraction DNA was extracted from the carcinoma samples, PBC of the cancer patients and PBC of normal controls, according to the standard method (Maniatis et al., 1982) .
Human L-myc probe The 1.8 kb human L-myc Smal-EcoRI fragment, used as a probe, was prepared from recombinant plasmid (PJB327) containing the fragment; the plasmid, a gift from J.D.
Minna, National Institute of Health, USA (Nau et al., 1985) , was obtained through G. Klein, Karolinska Institute, Stockholm, Sweden. The 1.8 kb L-myc fragment was purified by preparative agarose electrophoresis using low melting agarose. The probe was labelled by a2P dCTP to a specific activity of more than 108 c.p.m. fig-' Genomic DNAs (labelled numerically) were digested to completion with the restriction endonuclease EcoRI, under standard conditions. Ten gLg of the digest was subjected to electrophoresis on 0.7% agarose gels in 89 mM Tris-borate, 89 mM boric acid and 2 mM EDTA buffer at pH 8.0. Denatured DNA fragments were blotted onto a nylon membrane (Hybond-N, Amersham) according to standard procedure, as described by Southern (1975) .
Hybridisation, washing and autoradiography were carried out as previously described (Saranath et al., 1989) . Hind (Table I ). The relative ratios of the L-L, L-S and S-S fragments in the oral cancer patients were not significantly different from those observed in the 101 healthy individuals (X2 = 2.47, d.f. = 2, P<0.25).
In the total population studies (i.e. cancer patients plus controls) the genotype L-L was observed in 46/177 (25.9%), L-S in 86/177 (48.5%) and S-S in 46/177 (25.9%) individuals. Thus the two alleles L and S were equally distributed in the population, with the frequencies of the S and L alleles each being approximately 0.50.
Correlation of L-myc RFLP with clinical pattern
The relationships between L-myc RFLP and the level of differentiation, nodal metastasis, size of the primary tumour and TNM staging (UICC, 1988) , at the time of surgery for the primary tumour are summarised in Table II . The L-myc RFLP pattern was noted in the numerically labelled samples, and the data were compiled according to the clinical parameters. Of the 51 patients with poor to moderately differentiated tumours, 48 (94%) had either the L-S or S-S type pattern. X2 analysis revealed that the S fragment present as the L-S or S-S type pattern was significantly increased in poor to moderately differentiated oral tumours compared with well differentiated tumours (12/25 = 48%) (X2 = 18.8, d.f. = 1, P<0.001). The relationship between tumour size .. 1 ,2 .3 4 -.6 6.. 7 8 .9 10 11 I1 2 13. ' The RFLP pattern and allele frequencies in the PBC of the oral cancer patients was identical to the corresponding tumour tissues. bFigures in parentheses are percentages of the total recorded genotypes. cObserved allele frequencies consistent with the Hardy-Weinberg law. (Botstein et al., 1980) . One of the purposes of RFLP studies in cancer has been to establish a specific association of a particular proto-oncogene RFLP, with increased incidence of certain types of cancer, suggesting genetic predisposition (Krontiris et al., 1985; Heighway et al., 1986; Liderau et al., 1985 Liderau et al., , 1986 Kawashima et al., 1988; Kakehi & Yoshida, 1989 (Liderau et al., 1985) . On the other hand, in urothelial cancers (Ishikawa et al., 1988) and colon adenocarcinomas (Ceccherini-Nelli et al., 1987) , prevalence of specific Ha-ras polymorphic variants was not observed.
To investigate the status of L-myc RFLP fragments in squamous cell carcinoma of the oral cavity, we examined DNAs from the primary oral tumour tissues by Southern analysis. We observed a correlation between the presence of the S fragment either as S-S type or L-S type, and a poor to moderate level of differentiation of the tumours, as well as the large size of the tumours. An increased prevalence of the S fragment in the advanced stages III and IV of the oral cancers was also noticed. However, the number of patients in stages I and II was small (eight), and hence a statistically significant difference could not be seen on analysis. No correlation with either L or S fragment and nodal metastasis or recurrence of the malignancy was observed.
The polymorphic pattern in the PBC of the oral cancer patients was identical to that in the tumour tissue, showing no loss of alleles in the tumours. A preponderance of the L-L, L-S or S-S fragments was not observed in the oral cancer patients compared to normal healthy individuals. Thus, presence of a particular allele did not indicate predisposition to oral cancer. However, our results showed that oral cancer patients with a genotype including an S fragment are more likely to develop a poor to moderately differentiated tumour or a larger tumour than patients without an S fragment. The three reports of L-myc RFLP mentioned earlier were in the Japanese population (Kawashima et al., 1988; Kakehi & Yoshida, 1989; Ikeda et al., 1988 ). An analysis of the genotype distribution and the allelic frequencies from their combined data indicates a similar L-myc haplotype and allelic distribution pattern to that seen in the Indian population.
Recently, Kakehi and Yoshida (1989) observed a correlation between the presence of the S fragment of the L-myc RFLP in renal cell carcinoma and the metastatic potential of these tumours. Earlier Kawashima et al. (1987) had demonstrated an association between the S fragment of L-myc and metastasis to the nodes and distant organs in lung cancer. Our results did not show a correlation of L-myc RFLP with nodal metastasis. However, a close correlation with the stage of differentiation of the tumours and the L-myc RFLP was observed. In contrast Kakehi and Yoshida (1989) , in renal cancers, and Kawashima et al. (1988) , in lung cancers, did not observe such an association with the grade of tumour cell differentiation. An interesting question is how the presence of the S allele of L-myc could be related to the stage of differentiation selectively in oral cancers. Kawashima et al. (1988) have suggested possible explanations for the increased presence of one of the alleles of L-myc (S fragment) in lung tumours with greater potential for metastasis. They have suggested a direct role for another gene closely asociated to L-myc, a role for a partially different S-fragment-coded Lmyc protein, or a crucial role for the regulatory region of L-myc S fragment protein in metastasis. These possibilities could also hold true for the association of the S fragment with the stage of differentiation in oral cancers. However, the biological function of the L-myc protein and the complete nucleotide sequence of both the alleles are needed to elucidate the role of the L-myc S fragment in cancer.
